Purchases and Sales Made in Q3 2022 in Inhibikase Therapeutics, Inc. (IKT)
This table provides information about the institutional ownership of Inhibikase Therapeutics, Inc. (IKT) during Q3 2022. The information is specifically focused on institutions that hold shares of Inhibikase Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 09, 2022
Q3 2022
|
Blair William & CO
Chicago, IL |
BUY
|
- |
154K+ 616.0% |
$117K - $841K
|
179K
$358K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
24.1KNew |
$18.3K - $132K
|
24.1K
$48.2K
|
|
|
Oct 18, 2022
Q3 2022
|
Ccg Wealth Management, LLC
|
BUY
|
- |
20KNew |
$15.2K - $109K
|
20K
$40K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
15.9KNew |
$12.1K - $87K
|
15.9K
$31.9K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
7.5KNew |
$5.7K - $40.9K
|
7.5K
$15K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1- 0.75% |
$0.76 - $5.46
|
132
$264
|
|
|
Nov 10, 2022
Q3 2022
|
Redmond Asset Management, LLC
Henrico, VA |
SELL
|
- |
-205- 0.17% |
$156 - $1.12K
|
122K
$245K
|
|
|
Oct 19, 2022
Q3 2022
|
Retirement Planning CO Of New England, Inc.
Warwick, RI |
SELL
|
- |
-5.54K- 8.57% |
$4.21K - $30.2K
|
59.1K
$118K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-9.86K- 61.52% |
$7.49K - $53.8K
|
6.17K
$12.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-97.2K- 43.81% |
$73.9K - $531K
|
125K
$249K
|